Back
Sera Prognostics 10K Form
Sell
40
SERA
Sera Prognostics
Last Price:
8.25
Seasonality Move:
12.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SERA News And Ratings
See the #1 stock for the next 7 days that we like better than SERA
SERA Financial Statistics
Sales & Book Value
Annual Sales: | $306K |
---|---|
Cash Flow: | $4.28M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.99 |
Price / Book: | 4.17 |
Profitability
EPS (TTM): | -1.07000 |
---|---|
Net Income (TTM): | $-33.77M |
Gross Margin: | $96K |
Return on Equity: | 0% |
Return on Assets: | 0% |
Sera Prognostics Earnings Forecast
Key Sera Prognostics Financial Ratios
- The Gross Profit Margin over the past 5 years for SERA is 31.37%.
- The Selling, General & Administrative Expenses for SERA have been equal to 8,069.28% of Gross Profit Margin.
- The Research & Development expenses have been 4,975.49% of Revenue.
- The Interest Expense is -0.15% of Operating Income.
- The Net Earning history of SERA is -11,843.79% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Sera Prognostics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | SERA |
Website: | seraprognostics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SERA Technical Analysis vs Fundamental Analysis
Sell
40
Sera Prognostics (SERA)
is a Sell
Is Sera Prognostics a Buy or a Sell?
-
Sera Prognostics stock is rated a Sell
The current Sera Prognostics [SERA] share price is $8.26. The Score for SERA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.